{"transactions":[{"id":1708768,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2023-12-16T02:46:31.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":1300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 15, 2024 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2024."}],"balance_after":1300000,"derivative":{"exercise_price":0.247,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":1300000},"source":{"system":"sec-edgar","filing":"0001493152-23-045167","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315223045167/ownership.xml","form_type":"4"}},{"id":2077380,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2022-12-22T16:24:50.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 20, 2023 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2023."}],"balance_after":625000,"derivative":{"exercise_price":0.53,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001493152-22-036243","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315222036243/ownership.xml","form_type":"4"}},{"id":2471213,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2021-12-16T02:20:20.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 14, 2022 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2022."}],"balance_after":500000,"derivative":{"exercise_price":0.92,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000905718-21-001607","document":"matinas_fm4dec142021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571821001607/matinas_fm4dec142021.xml","form_type":"4"}},{"id":2924950,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-01-04T23:30:13.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":425000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2022 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2022."}],"balance_after":425000,"derivative":{"exercise_price":1.36,"expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":425000},"source":{"system":"sec-edgar","filing":"0001493152-21-000136","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315221000136/ownership.xml","form_type":"4"}},{"id":3103917,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-06-19T21:30:20.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. Vesting is performance based and tied to achievement of positive topline ENHANCE-IT data (the \"Milestone\"). The option vests as to 1/3 upon achievement of the Milestone, with the remaining options to vest 1/3 on the first anniversary of such Milestone and 1/3 on the second anniversary of such Milestone."}],"balance_after":175000,"derivative":{"exercise_price":0.815,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001493152-20-011535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315220011535/ownership.xml","form_type":"4"}},{"id":3321463,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-01-03T21:05:41.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021."}],"balance_after":350000,"derivative":{"exercise_price":2.27,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-20-000118","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315220000118/ownership.xml","form_type":"4"}},{"id":3659798,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Option (right to buy)","published_at":"2019-02-13T23:40:21.000Z","date":"2019-02-11","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests as to 25% of the shares on February 11, 2020 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on March 1, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":350000,"derivative":{"exercise_price":1.08,"expiration_date":"2029-02-10","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000905718-19-000112","document":"matinasbiofm4_feb112019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571819000112/matinasbiofm4_feb112019.xml","form_type":"4"}},{"id":3789642,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Option (right to buy)","published_at":"2018-10-16T20:31:25.000Z","date":"2018-10-15","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests as to 25% on October 25, 2019, and the remaining 75% of the shares will vest in equal monthly installments over the following thirty-six (36) months commencing on November 25, 2019. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":350000,"derivative":{"exercise_price":0.79,"expiration_date":"2028-10-15","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000905718-18-000853","document":"matinasbiofm4_oct152018.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571818000853/matinasbiofm4_oct152018.xml","form_type":"4"}},{"id":3876485,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":96125,"kind":"person","name":"Matkovits Theresa","position":1,"cik":"0001745393","reported_name":"Matkovits Theresa","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-03T17:26:47.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in four equal quarterly installments over one year beginning on June 29, 2018, subject to such individual continuing to be a Participant (as defined in the 2015 Equity Incentive Plan) on the relevant vesting dates."}],"balance_after":50000,"derivative":{"exercise_price":1.45,"expiration_date":"2028-06-29","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001123292-18-000853","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000112329218000853/edgar.xml","form_type":"4"}}]}